When to Terminate Buprenorphine Maintenance
The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals. Take advantage of these unique opportunities to engage your peers and get your questions answered! Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Credit Designations Available: AMA PRA Category […]
Fentanyl Medical/Counseling Treatment
The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals. Take advantage of these unique opportunities to engage your peers and get your questions answered!
When to Discuss Buprenorphine Taper
The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals. Take advantage of these unique opportunities to engage your peers and get your questions answered!
Comparing methods of buprenorphine treatment initiation in patients using fentanyl
The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals. Take advantage of these unique opportunities to engage your peers and get your questions answered!
The Addiction Landscape in 2023
The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals. Take advantage of these unique opportunities to engage your peers and get your questions answered!
Fentanyl and Opioid Use Disorder
The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals. Take advantage of these unique opportunities to engage your peers and get your questions answered!
Treating Pain and Addiction in Serious Illness
Two Models of MOUD Service Delivery – “Nurse Care Manager” and “Hub and Spoke”
MOUD Implementation
This roundtable discusses the role of champions, facilitators, barriers and how to assess readiness when implementing a MOUD program.
Intro to MOUD and the Formulations of Buprenorphine
This roundtable discusses three FDA-approved medications to treat opioid use disorder and resources for non-prescribing members of healthcare teams to support MOUD integration.
